Company Performance: UCB's financial results (revenue, profit, pipeline progress) directly impact investor confidence.

Industry Trends: Pharmaceutical sector growth, competitor actions, and overall healthcare demand influence UCB's outlook.

Regulatory Environment: Changes in drug approval processes or pricing regulations affect UCB's market access and profitability.

Macroeconomic Factors: Interest rates, inflation, and global economic conditions can impact investor risk appetite and stock valuations.

Market Sentiment: Overall investor optimism or pessimism toward the stock market affects UCB's stock price.

Clinical Trial Outcomes: Positive or negative results from UCB's clinical trials for new drugs drive significant price movements.

Patent Protection: Expiration or challenges to UCB's drug patents can impact future revenue streams and stock value.

Mergers and Acquisitions: Potential acquisitions or mergers involving UCB or its competitors can create price volatility.

Analyst Ratings: Recommendations from financial analysts can influence investor perception and trading activity.

Currency Exchange Rates: Fluctuations in currency rates impact UCB's earnings, especially from international sales.